Despite variations by age group and influenza virus type, the 2023-2024 influenza vaccine was protective against outpatient illness in pediatric and adult patients.

A dangerous bird flu, in other words, was suddenly circulating in mammals — mammals with which people have ongoing, extensive ...

New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say.

Using nasal swabs to identify a child’s asthma subtype may lead to more precise medication prescribing and development of ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

Early animal studies show that a single vaccine could protect the recipient from different variants of the coronaviruses that ...

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical ...

H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to ...

Researchers uncover how probiotics and diet shape the gut microbiome to boost vaccine efficacy, offering new avenues for ...